Veracyte appoints Rebecca Chambers as CFO effective July 19, 2021

VERACYTE, INC.

Rebecca Chambers, 43, appointed CFO effective July 19, 2021; previously CFO of Outset Medical.
Jane Alley resigns as acting CFO (same date) but remains VP, Corporate Controller and PAO.
Chambers gets $450K salary, $100K sign-on bonus, 67,000 stock options, 34,000 RSUs, and up to 13,600 performance-based RSUs.
Severance: 50% base salary for non-CIC termination; 150% plus full equity vesting for change-of-control termination.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jane Alley

Acting Chief Financial Officer

VCYT · VERACYTE, INC.

Effective: 2021-07-19
Successor: Rebecca Chambers
Filed: July 12, 2021, 7:59 PM ET

Jane Alley, Acting Chief Financial Officer, would be resigning from her position as Acting Chief Financial Officer, effective as of July 19, 2021

Appointed

Rebecca Chambers

Chief Financial Officer

VCYT · VERACYTE, INC.

Effective: 2021-07-19
Filed: July 12, 2021, 7:59 PM ET

On July 12, 2021, Veracyte, Inc. (the “Company”) announced that it appointed Rebecca Chambers, 43, as Chief Financial Officer, effective as of July 19, 2021

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jane Alley departed as Acting Chief Financial Officer at VERACYTE, INC..

Action: resigning
Role: Acting Chief Financial Officer

Exact text from the filing

Jane Alley, Acting Chief Financial Officer, would be resigning from her position as Acting Chief Financial Officer, effective as of July 19, 2021

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Rebecca Chambers was appointed as Chief Financial Officer at VERACYTE, INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On July 12, 2021, Veracyte, Inc. (the “Company”) announced that it appointed Rebecca Chambers, 43, as Chief Financial Officer, effective as of July 19, 2021

View on SEC.gov

VERACYTE, INC. filing history →

Source: SEC EDGAR

accession 0001384101-21-000118

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.